Application 208845

Type
NDA
Sponsor
FLEXION THERAPS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZILRETTATRIAMCINOLONE ACETONIDEFOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR32MG/VIALYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65250-003Zilrettatriamcinolone acetonide extended-release injectable suspensionPacira Pharmaceuticals, Inc.NDACurrent
70801-003Zilrettatriamcinolone acetonide extended-release injectable suspensionFlexion Therapeutics, Inc.NDACurrent
70801-003Zilrettatriamcinolone acetonide extended-release injectable suspensionFlexion Therapeutics, Inc.NDACurrent
70801-003Zilrettatriamcinolone acetonide extended-release injectable suspensionFlexion Therapeutics, Inc.NDACurrent
70801-003Zilrettatriamcinolone acetonide extended-release injectable suspensionFlexion Therapeutics, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80511SUPPL 2024-12-05
80498SUPPL 2024-12-04
79555SUPPL 2024-09-06
79554SUPPL 2024-09-06
65499SUPPL2020-12-04
65489SUPPL2020-12-03
61486SUPPL2019-12-31
61455SUPPL2019-12-26
53645ORIG2018-04-10
50022ORIG2017-10-12
49996ORIG2017-10-10